Literature DB >> 17416830

Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography.

H Matsuda1, S Mizumura, T Nagao, T Ota, T Iizuka, K Nemoto, N Takemura, H Arai, A Homma.   

Abstract

BACKGROUND AND
PURPOSE: In Alzheimer disease (AD), a peculiar regional cerebral blood flow (rCBF) abnormality has been reported in the posterior cingulate gyri and precunei, even at a very early stage. We performed a multicenter brain perfusion single-photon emission tomography (SPECT) study to evaluate the discrimination ability of an easy Z-score imaging system (eZIS) with a common normal data base between patients with very early AD at the stage of mild cognitive impairment and age-matched healthy controls.
MATERIALS AND METHODS: For a multicenter study, SPECT images of 40 patients with AD and 40 healthy volunteers were acquired from 4 gamma camera systems in 4 different institutions. Systematic differences of SPECT images between gamma cameras were corrected by using conversion maps calculated from the SPECT images of the same brain phantom. Receiver operating characteristic (ROC) analysis was performed to discriminate patients and controls by using a Z-score in the volume of interest (VOI), which had been defined as a region related to AD in subjects other than those in a multicenter study.
RESULTS: Bilateral posterior cingulate gyri, precunei, and parietal cortices were defined as a VOI showing rCBF reduction in very early AD. A new indicator of rCBF abnormality in the VOI provided 86% accuracy for distinction of AD and healthy controls in the multicenter study. The area under the ROC curve was 0.934.
CONCLUSION: Because an eZIS can use a common normal data base by converting site-specific SPECT data to the core data, the eZIS was useful for automated diagnosis of very early AD in routine studies in multiple institutions.

Entities:  

Mesh:

Year:  2007        PMID: 17416830      PMCID: PMC7977345     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

1.  Three brain SPECT region-of-interest templates in elderly people: normative values, hemispheric asymmetries, and a comparison of single- and multihead cameras.

Authors:  N J Lobaugh; C B Caldwell; S E Black; F S Leibovitch; R H Swartz
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

2.  Posterior cingulate cortex in Alzheimer's disease.

Authors:  S Minoshima; N L Foster; D E Kuhl
Journal:  Lancet       Date:  1994-09-24       Impact factor: 79.321

3.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

4.  Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.

Authors:  D Kogure; H Matsuda; T Ohnishi; T Asada; M Uno; T Kunihiro; S Nakano; M Takasaki
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

5.  Abnormal regional cerebral blood flow in childhood autism.

Authors:  T Ohnishi; H Matsuda; T Hashimoto; T Kunihiro; M Nishikawa; T Uema; M Sasaki
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

Review 6.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

7.  Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation.

Authors:  Sunao Mizumura; Shin-ichiro Kumita; Keiichi Cho; Makiko Ishihara; Hidenobu Nakajo; Masahiro Toba; Tatsuo Kumazaki
Journal:  Ann Nucl Med       Date:  2003-06       Impact factor: 2.668

8.  A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

Authors:  S Minoshima; K A Frey; R A Koeppe; N L Foster; D E Kuhl
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

9.  Preclinical prediction of Alzheimer's disease using SPECT.

Authors:  K A Johnson; K Jones; B L Holman; J A Becker; P A Spiers; A Satlin; M S Albert
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

10.  Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT.

Authors:  Koichiro Kaneko; Yasuo Kuwabara; Masayuki Sasaki; Koji Ogomori; Atsushi Ichimiya; Hirofumi Koga; Makoto Nakagawa; Kazutaka Hayashi; Hiroshi Honda
Journal:  Clin Nucl Med       Date:  2004-06       Impact factor: 7.794

View more
  40 in total

1.  Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer Disease.

Authors:  H Matsuda; S Mizumura; K Nemoto; F Yamashita; E Imabayashi; N Sato; T Asada
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

2.  Clinical profiles of late-onset psychiatric patients exhibiting incidental REM sleep without atonia.

Authors:  Hiroshige Fujishiro; Masato Okuda; Kunihiro Iwamoto; Seiko Miyata; Youta Torii; Shuji Iritani; Norio Ozaki
Journal:  J Neural Transm (Vienna)       Date:  2019-06-22       Impact factor: 3.575

3.  Challenges in the conduct of disease-modifying trials in AD: practical experience from a phase 2 trial of Tau-aggregation inhibitor therapy.

Authors:  C Wischik; R Staff
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

4.  Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer's Abeta Peptide.

Authors:  Daniel Paris; Nikunj Patel; Nowell J Ganey; Vincent Laporte; Amita Quadros; Michael J Mullan
Journal:  Int J Pept Res Ther       Date:  2010       Impact factor: 1.931

5.  ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis.

Authors:  Hirotaka Tanaka; Masamitsu Shimazawa; Masafumi Takata; Hideo Kaneko; Kazuhiro Tsuruma; Tsunehiko Ikeda; Hitoshi Warita; Masashi Aoki; Mitsunori Yamada; Hitoshi Takahashi; Isao Hozumi; Hiroshi Minatsu; Takashi Inuzuka; Hideaki Hara
Journal:  J Neurol       Date:  2013-02-23       Impact factor: 4.849

6.  A review of neuroimaging biomarkers of Alzheimer's disease.

Authors:  Tinu Varghese; R Sheelakumari; Jija S James; Ps Mathuranath
Journal:  Neurol Asia       Date:  2013       Impact factor: 0.183

7.  Does applying resolution recovery to normal databases confer an advantage over conventional 3D-stereotactic surface projection techniques?

Authors:  Nobuhiro Yada; Hideo Onishi; Masahiro Miyai; Kentarou Ozasa; Takashi Katsube; Keiichi Onoda; Masuo Haramoto; Yasushi Yamamoto; Shuhei Yamaguchi; Hajime Kitagaki
Journal:  Radiol Phys Technol       Date:  2017-02-04

8.  Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP.

Authors:  Kazunari Ishii; Tomonori Kanda; Takafumi Uemura; Naokazu Miyamoto; Toshiki Yoshikawa; Kenichi Shimada; Shingo Ohkawa; Satoshi Minoshima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-16       Impact factor: 9.236

9.  Imaging improves diagnosis of dementia with lewy bodies.

Authors:  Masaru Tateno; Seiju Kobayashi; Toshikazu Saito
Journal:  Psychiatry Investig       Date:  2009-11-21       Impact factor: 2.505

10.  Synapse stability in the precuneus early in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Kelly N Roberts; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.